Cell4Pharma Enters Distribution Agreement and Strategic Partnership with MatTek
MatTek Life Sciences will distribute Cell4Pharma’s ciPTEC renal cells and utilize the technology in the development of a new...
App Note: Human renal proximal tubule-on-a-chip for nephrotoxicity and drug interaction studies
Robust validated proximal tubule-on-a-chip Drug-induced organ toxicity accounts for 30% of all drugs that fail prior to reaching the market....
Drug-disposition-on-a-chip
Drug-disposition-on-a-chip: A European public private consortium to better predict the behaviour of drugs in humans by networked mini-organs. We are...
Webinar – How to predict drug-induced nephrotoxicity during drug discovery – AsraZeneca (ciPTEC)
Webinar - How to predict drug-induced nephrotoxicity during drug discovery - AsraZeneca (ciPTEC) How to predict drug-induced nephrotoxicity during drug...
Cell4Pharma’s European Distributors
Cell4Pharma's European Distribution Partners We proudly present Cell4Pharma's European distribution partners. Bio-Connect (Benulux) Clini Sciences (UK & Europe) Labclinics (Spain & Portugal) Tebu Bio...
Safety assessments for drug-induced kidney injury
Safety assessments for drug-induced kidney injury Obtaining mechanistic insights on adverse effects in the kidney during clinical trials is challenging. We...
Announcement: Strategic Partnership Accellerate
We are excited to announce acCELLerate as our strategic partner. Together we are able to provide researchers with validated assay ready...
The New Cell4Pharma Launch
Today we present you with the new Cell4Pharma (C4P), led by a highly skilled and motivated leadership team. We envision...